Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HW
476
DELISTED
Headwaters Inc
HW
| $18.7M | 0.05% |
+2,115,000
| New | +$21.8M |
|
|
RTK
477
DELISTED
Rentech, Inc.
RTK
| $18.7M | 0.05% |
+890,320
| New | +$19.2M |
|
478
Evercore
EVR
$13B
| $18.7M | 0.05% |
+475,300
| New | +$18.4M |
|
479
Devon Energy
DVN
$50B
| $18.6M | 0.05% |
+358,100
| New | +$19.9M |
|
|
CIT
480
DELISTED
CIT Group Inc.
CIT
| $18.6M | 0.05% |
+398,300
| New | +$17.6M |
|
481
Cleveland-Cliffs
CLF
$6.94B
| $18.6M | 0.05% |
+1,142,800
| New | +$21.9M |
|
482
Portland General Electric
POR
$6B
| $18.5M | 0.05% |
+605,200
| New | +$18.8M |
|
|
ARTC
483
DELISTED
ARTHROCARE CORP
ARTC
| $18.5M | 0.05% |
+534,400
| New | +$18.4M |
|
|
STMP
484
DELISTED
Stamps.com, Inc.
STMP
| $18.4M | 0.05% |
+467,251
| New | +$15.6M |
|
485
ICU Medical
ICUI
$4.14B
| $18.3M | 0.05% |
+253,600
| New | +$16.8M |
|
486
Children's Place
PLCE
$52.9M
| $18.2M | 0.05% |
+332,560
| New | +$16.8M |
|
|
ALR
487
DELISTED
Alere Inc
ALR
| $18.2M | 0.05% |
+741,124
| New | +$19.2M |
|
488
WD-40
WDFC
$3.18B
| $18.1M | 0.05% |
+332,300
| New | +$18.3M |
|
489
Sally Beauty Holdings
SBH
$1.45B
| $18M | 0.05% |
+579,800
| New | +$17.5M |
|
|
WP
490
DELISTED
Worldpay, Inc.
WP
| $18M | 0.05% |
+653,000
| New | +$16.2M |
|
|
INVX
491
Innovex International
INVX
$1.83B
| $18M | 0.05% |
+199,100
| New | +$17.4M |
|
|
VER
492
DELISTED
VEREIT, Inc.
VER
| $18M | 0.05% |
+235,520
| New | +$18.8M |
|
493
Howard Hughes
HHH
$3.92B
| $17.9M | 0.05% |
+167,945
| New | +$15.8M |
|
494
Radian Group
RDN
$5.22B
| $17.9M | 0.05% |
+1,543,700
| New | +$18.7M |
|
|
BBBY
495
Bed Bath & Beyond
BBBY
$493M
| $17.9M | 0.05% |
+845,851
| New | +$14.2M |
|
496
Quanta Services
PWR
$86.7B
| $17.9M | 0.05% |
+677,199
| New | +$18.8M |
|
497
Equifax
EFX
$22.1B
| $17.9M | 0.05% |
+303,895
| New | +$18.3M |
|
498
Sabesp
SBS
$19.8B
| $17.9M | 0.05% |
+8,869,219
| New | +$23M |
|
499
Public Service Enterprise Group
PEG
$40B
| $17.9M | 0.05% |
+548,000
| New | +$18.7M |
|
500
Avery Dennison
AVY
$12.9B
| $17.8M | 0.05% |
+415,700
| New | +$17.7M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.